Aysel Korkmaz Yatkın
+ 90 (212) 354 00 22
Aysel Korkmaz Yatkın joined the firm in 2008 and became a partner in 2020. She specializes in intellectual property with a special focus on patents and utility models and the chair of insurance and reinsurance practice area.
With almost 12-years of experience on patents, she has been providing consultancy on all matters related to the patent law and has been leading numerous patent actions. With a vast advisory and litigation expertise particularly with regards to protection of patent rights, Aysel Korkmaz Yatkın also represents various pharmaceutical companies before the Ministry of Health in relation to the regulatory matters and gives support to these companies on regulatory matters during the audits conducted before the Ministry of Health.
Aysel Korkmaz Yatkın also advises clients in various industries including but not limited to pharmaceutical industry, information and technology industries.
Should the Lawyer Follow the Judge’s Misdirection?
IAM - International Report, Co-Author, 14.09.2021
A Battle to Benefit from EPC 138/3
Kluwer Patent Blog, Co-Author, 02.12.2020
New Code of Civil Procedure Extends Deadlines in Patent Litigation
Kluwer Patent Blog, Co-Author, 06.11.2020
Innovator Companies Seek to Protect Themselves Against Generic Companies
Managing IP - Future of IP: Turkey 2020, Co-Author, 19.03.2020
Unfair Approach of Turkish IP Courts while Assessing “Bolar Exemption”
Managing IP – International Briefings, Co-Author, 13.02.2020
Conversion of a Non-Examined Patent to an Examined Patent During Court Proceedings
Kluwer Patent Blog, Co-Author, 30.10.2019
Discovery of Evidence Not being Subject to Bolar Exemption
Managing IP – International Briefings, Co-Author, 03.05.2019
Stay of Execution to Mandatory Arbitration
Gün + Partners, Co-Author, 17.10.2018
First Damages Claim Decision in Pharma Sector for Unjust Preliminary Injunction
IAM – International Report, Co-Author, 23.05.2018
Article 138/3 of EPC Applies During Pending Proceedings
Managing IP – International Briefings, Co-Author, 03.04.2017
Direct Applicability of European Patent Convention While Invalidation Actions Pending
IAM – International Report, Co-Author, 22.03.2017
Turkey: Is new IP Code in line with EPC?
Managing IP – International Briefings, Co-Author, 22.02.2017
Turkey is Welcoming The Long Awaited Industrial Property Code
Gün + Partners, Co-Author, 10.01.2017
IP Court Rejects Court of Appeal View on Second Medical Use Claims
IAM International Report, Co-Author, 22.06.2016
Compensation Lawsuits For Alleged Injustice In Pharmaceutical Sector, Gün + Partners, Speaker, 02.12.2020
Guarantee Amounts for Preliminary Injunction Decisions in Patent Litigation, AIPPI Turkey – Current Developments on Intellectual Property Practice Seminar, Speaker, Istanbul, Turkey, 06.12.2019
Law, Patent and Trademark Attorneys Association - Patent Attorneyship Pre-Exam Training, Instructor, Istanbul, Turkey, 29.10.2019
Law, Patent and Trademark Attorneys Association - Patent Attorneyship Pre-Exam Training, Instructor, Istanbul, Turkey, 06.10.2019
Employee Inventions, Model Court of Justice 2019, Speaker, Ankara, Turkey, 10.02.2019
Ex-parte Preliminary Injunction (Case study), Taylor Wessing - Europeans Patent Forum, Speaker, Munich, Germany, 11.10.2018
Patent and Trademark Law Applications in the scope of SME No. 6769, Hukuk Akademisi seminar, Instructor, Istanbul, Turkey, 02.06.2018
Patent protection in pharmaceutical product and second medical use claims, relationship between patent and marketing authorization, and cases, DETTO InventUP Health Program, Speaker, Izmir, Turkey, 16.01.2018
Turkey’s New Industrial Property Code (no:6769), Gün + Partners Seminar, Speaker, Istanbul, Turkey, 10.02.2017
- Association Internationale pour la Protection de la Propriété Intellectuelle (AIPPI)
- Better Justice Association
- 2007, International Commercial and Business Law, University of East Anglia, Norwich, England (Degree of Master of Law)
- 2004, Faculty of Law, Yeditepe University, Istanbul LL.B.
- 1999, Akyurt Health High School, Ankara